On Demand Education

Integrating new technology into the management of non-dysplastic Barrett’s esophagus patients

Castle Biosciences hosted a case-based panel discussion at DDW 2023 highlighting how TissueCypher aids in the management of non-dysplastic Barrett’s esophagus patients.

Lipham J, Muthusamy R, Khara H

Individualized Risk Prediction in Barrett’s Esophagus

Jul 2016

Medical Laboratory Observer

Aaron DeWard

A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett’s Esophagus

Feb 2017

Rebecca J. Critchley-Thorne

A Tissue Systems Pathology Assay for High-Risk Barrett’s Esophagus

May 2016

Rebecca J. Critchley-Thorne

A Cost-Effectiveness Analysis of an Adenocarcinoma Risk Prediction Multi-Biomarker Assay for Patients with Barrett’s Esophagus

Oct 2019

IDgenetix Resources: An Introduction to Pharmacogenomic Testing for Psychiatrists

Nov 2021

Dr. Mondimore, Behnaz Sarrami, MS, PHARMD, Medical Science Liasion, PGX

IDgenetix Resources: Understanding the ABCB1 Gene

Nov 2021

Behnaz Sarrami, MS, PHARMD, Medical Science Liasion, PGX

IDgenetix Resources: Understanding the COMT Gene

Nov 2021

Behnaz Sarrami, MS, PHARMD, Medical Science Liasion, PGX

IDgenetix Resources: Understanding Methylation

Nov 2021

Behnaz Sarrami, MS, PHARMD, Medical Science Liasion, PGX

IDgenetix Resources: Understanding the MTHFR Gene

Nov 2021

Behnaz Sarrami, MS, PHARMD, Medical Science Liasion, PGX

IDgenetix Resources: Phenoconversion, the Blind Spot of PGx

Nov 2021

Behnaz Sarrami, MS, PHARMD, Medical Science Liasion, PGX

Understanding the Power of Pharmacogenomic Testing When Treating Depression

Aug 2021